Delivery Order SPE2DB20D1004-SPE2DB22FF1S5
Award Date
1/27/22
Potential Completion Date
1/28/22
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,046.02, is a Firm Fixed Price Delivery Order for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award, valued at $1,702.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG tablets, a medical product, with a completion date of September 13, 2024. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,940.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB22FN9H2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,213.48 firm fixed-price delivery order is for the pharmaceutical product JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,130.22, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The delivery order is a firm fixed price contract with a completion date of February 26, 2024. Amerisourcebergen Drug Corp, through its...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,110.83, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,232.79 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically JUNEL FE 1MG-20MCG 168 tablets. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $237.23 to Amerisourcebergen Drug Corporation for the supply of 4561522540 JOLESSA 0.15 MG-0.03 MG TABLET 91S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania within the period of performance between July 17-18, 2023. The Defense Logistics Agency utilizes numerous contracts to support the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,488.06 Firm Fixed Price Delivery Order contract is for the supply of JUNEL FE 1 MG-20 MCG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. While the award is not associated with a set-aside, Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,344.85 firm fixed-price delivery order is for the supply of JUNEL 1.5 MG-30 MCG TABLET 21S, a medical commodity. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...